Literature DB >> 8257130

Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans.

H Vanden Bossche1, P Marichal, L Le Jeune, M C Coene, J Gorrens, W Cools.   

Abstract

As in other pathogenic fungi, the major sterol synthesized by Cryptococcus neoformans var. neoformans is ergosterol. This yeast also shares with most pathogenic fungi a susceptibility of its cytochrome P-450-dependent ergosterol synthesis to nanomolar concentrations of itraconazole. Fifty percent inhibition of ergosterol synthesis was reached after 16 h of growth in the presence of 6.0 +/- 4.7 nM itraconazole, and complete inhibition was reached at approximately 100 nM itraconazole. This inhibition coincided with the accumulation of mainly eburicol and the 3-ketosteroid obtusifolione. The radioactivity incorporated from [14C]acetate in both compounds represents 64.2% +/- 12.9% of the radioactivity incorporated into the sterols plus squalene extracted from cells incubated in the presence of 10 nM itraconazole. The accumulation of obtusifolione as well as eburicol indicates that itraconazole inhibits not only the 14 alpha-demethylase but also (directly or indirectly) the NADPH-dependent 3-ketosteroid reductase, i.e., the enzyme catalyzing the last step in the demethylation at C-4. This latter inhibition obviates the synthesis of 4,4-demethylated 14 alpha-methylsterols that may function at least partly as surrogates of ergosterol. Eburicol and obtusifolione are unable to support cell growth, and the 3-ketosteroid has been shown to disturb membranes. The complete inhibition of ergosterol synthesis and the accumulation of the 4,4,14-trimethylsterol and of the 3-ketosteroid together with the absence of sterols, such as 14 alpha-methylfecosterol and lanosterol, which can partly fulfill some functions of ergosterol, are at the origin of the high activity of itraconazole against C. neoformans. Fifty percent inhibition of growth achieved after 16 h of incubation in the presence of 3.2 +/- 2.6 nM itraconazole.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8257130      PMCID: PMC192235          DOI: 10.1128/AAC.37.10.2101

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Molecular genetic studies on the mode of action of azole antifungal agents.

Authors:  S L Kelly; J Rowe; P F Watson
Journal:  Biochem Soc Trans       Date:  1991-08       Impact factor: 5.407

2.  Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans.

Authors:  H van den Bossche; G Willemsens; W Cools; W F Lauwers; L Le Jeune
Journal:  Chem Biol Interact       Date:  1978-04       Impact factor: 5.192

3.  Correlation between molecular shape and hexagonal HII phase promoting ability of sterols.

Authors:  J Gallay; B De Kruijff
Journal:  FEBS Lett       Date:  1982-06-21       Impact factor: 4.124

Review 4.  Biochemical approaches to selective antifungal activity. Focus on azole antifungals.

Authors:  H Vanden Bossche; P Marichal; J Gorrens; M C Coene; G Willemsens; D Bellens; I Roels; H Moereels; P A Janssen
Journal:  Mycoses       Date:  1989       Impact factor: 4.377

5.  Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages.

Authors:  D T Hart; W J Lauwers; G Willemsens; H Vanden Bossche; F R Opperdoes
Journal:  Mol Biochem Parasitol       Date:  1989-03-01       Impact factor: 1.759

6.  Multiple functions for sterols in Saccharomyces cerevisiae.

Authors:  R J Rodriguez; C Low; C D Bottema; L W Parks
Journal:  Biochim Biophys Acta       Date:  1985-12-04

7.  The structural requirements of sterols for membrane function in Saccharomyces cerevisiae.

Authors:  W D Nes; G G Janssen; F G Crumley; M Kalinowska; T Akihisa
Journal:  Arch Biochem Biophys       Date:  1993-02-01       Impact factor: 4.013

8.  24,25-Epoxysterol metabolism in cultured mammalian cells and repression of 3-hydroxy-3-methylglutaryl-CoA reductase.

Authors:  F R Taylor; A A Kandutsch; A K Gayen; J A Nelson; S S Nelson; S Phirwa; T A Spencer
Journal:  J Biol Chem       Date:  1986-11-15       Impact factor: 5.157

9.  Characterization of an azole-resistant Candida glabrata isolate.

Authors:  H vanden Bossche; P Marichal; F C Odds; L Le Jeune; M C Coene
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

10.  Requirement for a second sterol biosynthetic mutation for viability of a sterol C-14 demethylation defect in Saccharomyces cerevisiae.

Authors:  F R Taylor; R J Rodriguez; L W Parks
Journal:  J Bacteriol       Date:  1983-07       Impact factor: 3.490

View more
  32 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray.

Authors:  M D De Backer; T Ilyina; X J Ma; S Vandoninck; W H Luyten; H Vanden Bossche
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 4.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

5.  Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates.

Authors:  P Marichal; J Gorrens; L Laurijssens; K Vermuyten; C Van Hove; L Le Jeune; P Verhasselt; D Sanglard; M Borgers; F C Ramaekers; F Odds; H Vanden Bossche
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

6.  A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.

Authors:  H Sanati; P Belanger; R Fratti; M Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

7.  Characterization of the Saccharomyces cerevisiae ERG27 gene encoding the 3-keto reductase involved in C-4 sterol demethylation.

Authors:  D Gachotte; S E Sen; J Eckstein; R Barbuch; M Krieger; B D Ray; M Bard
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

8.  In vitro and in vivo effects of 14alpha-demethylase (ERG11) depletion in Candida glabrata.

Authors:  H Nakayama; N Nakayama; M Arisawa; Y Aoki
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.

Authors:  Hugo Vanden Bossche; Jannie Ausma; Hilde Bohets; Karen Vermuyten; Gustaaf Willemsens; Patrick Marichal; Lieven Meerpoel; Frank Odds; Marcel Borgers
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 10.  Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches.

Authors:  B D Alexander; J R Perfect
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.